Cumberland Pharmaceuticals Inc. (CPIX) vs Genelux Corporation (GNLX)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
GNLX
Genelux Corporation
$2.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CPIX vs GNLX
growth of $100 · dividends reinvested · last 4yCPIX +228.4% (+34.6%/yr)GNLX -57.7% (-19.4%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX GNLX
CPIX vs GNLX: by the numbers
- •GNLX is the larger company ($114M vs $107M market cap).
- •Both run net losses; CPIX's is the smaller (-33.92% vs -422412.50% net margin).
- •CPIX pays a dividend (21.16% yield), while GNLX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | GNLX |
|---|---|---|
| P/S ratio | 3.42 | 14236.83 |
| P/B ratio | 6.13 | 7.07 |
Profitability
| Metric | CPIX | GNLX |
|---|---|---|
| Gross margin | 83.37% | -7075.00% |
| Operating margin | -6.27% | -415175.00% |
| Net margin | -33.92% | -422412.50% |
| ROE | -60.82% | -209.73% |
| ROIC | -34.77% | -192.18% |
Dividends
| Metric | CPIX | GNLX |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | GNLX |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | N/A |
Frequently asked
- Does CPIX or GNLX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while GNLX has no payments in the available dividend history.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEGenelux ROECumberland Pharmaceuticals operating marginGenelux operating marginCumberland Pharmaceuticals revenue growthGenelux revenue growthCumberland Pharmaceuticals free cash flowGenelux free cash flow
Cumberland Pharmaceuticals & Genelux appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.